Sadayuki Hiroi

2.2k citations
50 papers · 1.8k indexed · h-index 23

Sadayuki Hiroi

50 papers receiving 1.7k citations

Peers

Sadayuki Hiroi
Comparison fields: 5 of 99
  • Biochemistry 167
  • Hepatology 153
  • Cancer Research 214
  • Immunology 300
  • Oncology 310
Replace Yoshinori Otsuki with:
Yoshinori Otsuki Japan
Jane Bond United Kingdom
Jörg Hoffmann Germany
Fawzia Bardag‐Gorce United States
Monica Morini Italy
Baoheng Du United States
Tadayoshi Okumura Japan
Naomi Sakashita Japan
Jinshun Pan China
Michael K. Jones United States
Sadayuki Hiroi relative to Yoshinori Otsuki Japan Yoshinori Otsuki's profile →
Citations per field
00.5×1.5×2.3×
Yoshinori Otsuki · 1×
Citations per year

Countries citing papers authored by Sadayuki Hiroi

Since Specialization
Citations

This map shows the geographic impact of Sadayuki Hiroi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sadayuki Hiroi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sadayuki Hiroi more than expected).

Fields of papers citing papers by Sadayuki Hiroi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sadayuki Hiroi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sadayuki Hiroi. The network helps show where Sadayuki Hiroi may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Sadayuki Hiroi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sadayuki Hiroi Line = papers co-authored together Sadayuki Hiroi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20187
2 201719
3 201621
4 201522
5 201323
6 201148
7 2011184
8 201041
9 2010226
10 20092
11 200910
12 20093
13 200830
14 200767
15 200655
16 200327
17 20039
18 20027
19 200180
20 199814

About Sadayuki Hiroi

Sadayuki Hiroi is a scholar working on Biotechnology, Biochemistry and Oncology, having authored 50 papers that have together received 1.8k indexed citations. Recurring topics across this work include Telomeres, Telomerase, and Senescence (7 papers), Epigenetics and DNA Methylation (5 papers), Occupational and environmental lung diseases (4 papers), Cancer Research and Treatments (4 papers), Immune Cell Function and Interaction (4 papers), Amino Acid Enzymes and Metabolism (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers) and Lung Cancer Treatments and Mutations (3 papers). The work is most often cited by research in Biochemistry (167 citations), Hepatology (153 citations) and Cancer Research (214 citations). Sadayuki Hiroi has collaborated with scholars based in Japan, United States and France. Frequent co-authors include Toshiaki Kawai, Kuniaki Nakanishi, Susumu Tominaga, Shinsuke Aida, Shuhji Seki, Manabu Kinoshita, Fumiyuki Kumaki, Hiroyuki Nakashima, Masahiro Nakashima and Hiromi Miyazaki. Their work appears in journals such as American Journal of Clinical Pathology, Pathology International, Lung Cancer, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin and Human Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026